DOPAMINE-Β-HYDROXYLASE INHIBITORS

This invention relates to: (a) compounds of formula I (with R1 to R5 and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-β-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of...

Full description

Saved in:
Bibliographic Details
Main Authors CARDONA Francisco, KISS Laszlo, BELIAEV Alexander, SOARES DA SILVA Patricio, PINTO Rui, PALMA Nuno, ROSSI Tino
Format Patent
LanguageEnglish
Spanish
Published 24.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to: (a) compounds of formula I (with R1 to R5 and A as defined herein) and pharmaceutically acceptable salts or solvates thereof that are useful as dopamine-β-hydroxylase inhibitors; (b) pharmaceutical compositions comprising such compounds, salts or solvates; (c) the use of such compounds, salts or solvates in therapy; (d) therapeutic methods of treatment using such compounds, salts or solvates; and (e) processes and intermediates useful for the synthesis of such compounds. La presente se refiere a: (a) compuestos de la fórmula I (con R1 a R5 y A de acuerdo con lo definido en la presente memoria) y sales o solvatos aceptables para uso farmacéutico de los mismos que son útiles como inhibidores de dopamina-ß-hidroxilasa; (b) composiciones farmacéuticas que comprenden tales compuestos, sales o solvatos; (c) el uso de tales compuestos, sales o solvatos en una terapia; (d) métodos terapéuticos de tratamiento por el uso de tales compuestos, sales o solvatos; y (e) procesos e intermedios útiles para la síntesis de tales compuestos. (ver Fórmula).
Bibliography:Application Number: MX2021014941